Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Peg-Intron 150µg*


Contraindicated
Reproductive toxicity in animals

Contraindicated
Peg-Intron 150µg* :
Type Medicine Non Marketed
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory MSD
Responsible Party Schering-Plough (Brinny) Co subsidiary of Schering-Plough Corporation, USA
Origin Ireland
Manufacturer Schering Plough (Brinny)
Origin Ireland
ATC L03AB10

Your comment will appear shortly after approval

Peg-Intron 150µg* :

Revision Date : 25/06/2015


Effect Frequency
Abdominal discomfort Common
Abdominal distension Common
Abdominal pain Very Common
Abdominal pain upper Very Common
Abnormal behaviour Common
Abnormal dreams Common
Acne Common
Affect lability Very Common
Aggression Common
Agitation Common
Alopecia Very Common
Amenorrhoea (amenorrhea) Common
Amnesia Common
Amylase increased Not known
Anaemia Very Common
Anaphylactic reactions Not known
Anaphylactic shock Not known
Anger Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anti-thyroid antibody positive Uncommon
Anxiety Very Common
Apathy Common
Aphthous ulcer Common
Aplasia pure red cell (PRCA) Not known
Aplastic anemia Very rare
Arrhythmia Rare
Arthralgia (Pain joint) (Joint ache) Very Common
Arthritis Common
Ascariasis Uncommon
Asthenia Very Common
Ataxia Common
Autoimmune disorder Not known
Back pain Common
Bacterial infection Common
Bipolar disorders Rare
Blood lactic acid increased Not known
Blood thyroid stimulating hormone increased Common
Bone pain Uncommon
Breast pain Common
Bronchitis Common
Cardiomyopathy Rare
CD4 lymphocytes decreased Not known
Cellulitis Uncommon
Cerebral haemorrhage Very rare
Cerebral ischaemia Very rare
Cheilitis Common
Cheilosis Common
Chest discomfort Common
Chest pain Common
Chills Very Common
Colitis ischaemic Rare
Colitis ulcerative Very rare
Completed suicide Uncommon
Confusional state Common
Congestive heart failure Rare
Conjunctival haemorrhage Uncommon
Conjunctivitis Common
Constipation Common
Contusion Uncommon
Cough Very Common
Crying Common
Cutaneous sarcoidosis Rare
Deafness Common
Decreased appetite Very Common
Dehydration Common
Depressed mood Uncommon
Depression Very Common
Dermatitis Common
Dermatitis atopic Uncommon
Diabetes mellitus Uncommon
Diabetic ketoacidosis Rare
Diarrhoea (Diarrhea) Very Common
Disturbance in attention Very Common
Dizziness Very Common
Drug hypersensitivity Uncommon
Dry eye Common
Dry mouth (Xerostomia) Very Common
Dry skin Very Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Common
Dysmenorrhoea Uncommon
Dyspepsia Common
Dysphonia Common
Dyspnoea (dyspnea) Very Common
Eczema Common
Emotional disorder Uncommon
Encephalopathy Very rare
Enterobiasis Uncommon
Epistaxis (Nasal bleeding) Common
Erectile dysfunction Common
Erythema Common
Erythema multiforme Very rare
Eye irritation Common
Eye pain Common
Eye pruritus Uncommon
Face oedema Common
Facial pain Uncommon
Facial paralysis Not known
Fatigue Very Common
Fear Uncommon
Feeling abnormal Common
Feeling cold Common
Flatulence Common
Flushing Common
Fungal infection Common
Furuncle Common
Gamma-GT increased Not known
Gastroenteritis Uncommon
Gastrooesophageal reflux disease Common
Gingival bleeding (Gingival hemorrhage) Common
Gingivitis Common
Glossitis Common
Glossodynia Common
Growth retardation Not known
Haemolytic anemia Common
Haemorrhoids Common
Hair texture abnormal Common
Hallucination Uncommon
Headache Very Common
Hepatitis Not known
Hepatomegaly Common
Herpes simplex Common
Herpes zoster Uncommon
Homicidal ideation Not known
Hyperaesthesia Common
Hyperbilirubinaemia Common
Hyperhidrosis Common
Hypersensitivity type I Not known
Hypertension Common
Hyperthyroidism Common
Hypertonia Common
Hypertriglyceridaemia Uncommon
Hyperuricaemia Common
Hypoacusis Common
Hypocalcaemia Common
Hypoesthesia Common
Hypotension Common
Hypothyroidism Common
Immune thrombocytopenic purpura Not known
Increased appetite Common
Increased upper airway secretion Common
Influenza Common
Influenza-like illness Very Common
Injection site dryness Common
Injection site erythema Very Common
Injection site infection Uncommon
Injection site inflammation Very Common
Injection site necrosis Rare
Injection site pain Common
Injection site pruritus Common
Injection site rash Common
Injection site reaction Very Common
Insomnia Very Common
Interstitial pneumonitis Very rare
Irritability Very Common
Keratitis Uncommon
Lacrimal disorder Common
Lactic acidosis Not known
Laryngeal pain Common
Lethargy Uncommon
Leucopenia (Leukopenia) Very Common
Libido decreased Common
Lipase increased Not known
Lipodystrophy acquired Not known
Lower respiratory tract infection Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Very rare
Lymphadenopathy Common
Macular oedema Rare
Maculopapular rash Common
Malaise Very Common
Mania Not known
Memory impairment Common
Menorrhagia Common
Menstrual disorder Common
Migraine Common
Mitochondrial toxicity Not known
Mononeuropathy Not known
Mood altered Common
Mouth ulceration Common
Muscle contracture Uncommon
Muscle spasms Common
Muscle twitching (Muscle twitch) Uncommon
Muscle weakness Uncommon
Musculoskeletal pain Very Common
Myalgia Very Common
Myocardial infarction Uncommon
Myocardial ischaemia Very rare
Myositis Rare
Nail disorders Common
Nasal congestion Common
Nasal discomfort Uncommon
Nasopharyngitis Common
Nausea Very Common
Nervousness Common
Neuralgia Common
Neuropathy peripheral Uncommon
Neutropenia Very Common
Night sweats Common
Nightmares Uncommon
Oedema peripheral Common
Optic neuritis Rare
Oral candidiasis Not known
Oral herpes Common
Oral pain Common
Otalgia (Earache) (Ear pain) Uncommon
Otitis media Common
Ovarian disorder Common
Pain Very Common
Pain in extremity (Pain in limb) Common
Pallor Uncommon
Palpitations Common
Pancreatitis Uncommon
Panic attack Uncommon
Papilloedema Rare
Paraesthesia (paresthesia) Common
Pericardial effusion Not known
Pericarditis Rare
Pharyngitis Very Common
Pharyngitis streptococcal Common
Photophobia Common
Photosensitivity reaction Common
Pigmentation disorder Uncommon
Pneumonia Uncommon
Pollakiuria (Urinary frequency) Common
Polyuria Common
Poor quality sleep Common
Prostatitis Common
Proteinuria Uncommon
Pruritus Very Common
Psoriasis Common
Psychomotor hyperactivity (Psychomotor restlessness) Uncommon
Psychotic disorders Uncommon
Pulmonary arterial hypertension Not known
Pulmonary fibrosis Not known
Pyrexia Very Common
Rash erythematous Common
Renal failure Rare
Respiratory disorder Common
Respiratory tract congestion Common
Restlessness Common
Retinal artery occlusion Rare
Retinal detachment Not known
Retinal exudates Uncommon
Retinal haemorrhage Rare
Retinal vein occlusion Rare
Retinopathy Rare
Rhabdomyolysis Rare
Rheumatoid arthritis Rare
Rhinitis Common
Rhinorrhoea Common
Sarcoidosis Rare
Seizures Rare
Sepsis (Systemic infection) (Sepsis state) Common
Sexual dysfunction Common
Sinus congestion Common
Sinusitis Common
Skin discolouration (Dyschromia) Uncommon
Skin exfoliation (Flaking skin) Uncommon
Skin rash Very Common
Sleep disorder (Sleep disturbance) Common
Somnolence Common
Stevens-Johnson syndrome Very rare
Stomatitis Common
Suicidal ideation Uncommon
Suicide attempt Uncommon
Syncope Common
Systemic lupus erythematosus Not known
Tachycardia Common
Thirst Common
Thrombocytopenia (Thrombopenia) Common
Thrombotic thrombocytopenic purpura (TTP) Not known
Thyroglobulin increased Common
Thyroid disorder Not known
Tinnitus Common
Tongue pigmentation Not known
Tooth disorder Common
Tremor Common
Upper respiratory tract infection Common
Urinary tract infection Uncommon
Urine abnormality Common
Urticaria Common
Vaginal disorder Common
Vasculitis Rare
Vertigo Common
Viral infection Very Common
Vision blurred Common
Visual acuity reduced Rare
Visual disturbance Common
Visual field defect Rare
Vogt-Koyanagi-Harada syndrome Not known
Vomiting Very Common
Weight decreased (Weight loss) Very Common
Wheezing Uncommon

Different Units By MoH Code

Revision Date : 31/07/2007

Peg-Intron 150µg*  MoH 2961 :
Form Powder and solvent for solution for injection
Packaging Bottle
Package Size 1+1
Strength 150µg/0.5ml
Storage Condition 2-8°C Do not freeze
NSSF ✘
Quarantine ✘
Reg. Number 973734/02
Submission date 01/01/2002
Registration Year 2004
Archived Date 2014


NB : Change of agent in 2007 from Kettaneh Pharma to Abela Freres

Price Comparison

● Country: Italy
● Package Size: 1
● Public Price: 379.04 EUR ( 36,719,879.04 LBP )
● Pack size unit used: 1
● Cost/Unit: 379,04 EUR ( 36,716,004.00 LBP )
● Pricing Date: 17/06/2019
● Type: Medicine Authorised

● Country: KSA
● Package Size: 1x0.5ml
● Public Price: 1507.55 SAR ( 35,638,482.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1507,55 SAR ( 35,625,480.00 LBP )
● Reference: sfda
● Pricing Date: 05/03/2020
● Type: Medicine Non Marketed

● Country: Qatar
● Package Size: 1 Vial Dry + 1 solvent Ampoules (0.5ml)
● Public Price: 1373.25 QAR ( 33,724,273.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 1373,25 QAR ( 33,718,134.00 LBP )
● Pharmacy Price: 1127.84 QAR ( 27697494.72 LBP )
● Pricing Date: 20/07/2017
● Type: Medicine Non Marketed

● Country: Oman
● Package Size: 1 + 1
● Public Price: 144.56 OMR ( 33,354,907.04 LBP )
● Pack size unit used: 1
● Cost/Unit: 144,56 OMR ( 33,225,696.00 LBP )
● Pricing Date: 13/09/2017
● Type: Medicine Non Marketed

● Country: Abu Dhabi
● Package Size: 1 Vial (Dry) + 1 Solvent Ampoule (0.5ml)
● Public Price: 1337.5 AED ( 32,315,337.50 LBP )
● Pack size unit used: 1
● Cost/Unit: 1337,5 AED ( 32,303,257.00 LBP )
● Pharmacy Price: 1139.54 AED ( 27532425.94 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 1
● Public Price: 127.24 BHD ( 30,249,274.16 LBP )
● Pack size unit used: 1
● Cost/Unit: 127,24 BHD ( 30,192,218.00 LBP )
● Reference: nhra
● Pricing Date: 28/08/2017
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 1x0,5ml+1
● Public Price: 7439.96 CZK ( 28,413,207.24 LBP )
● Pack size unit used: 1
● Cost/Unit: 7439,96 CZK ( 28,409,541.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 4x0.5ml
● Public Price: 1119.6 EUR ( 108,462,369.60 LBP )
● Pack size unit used: 4
● Cost/Unit: 279,9 EUR ( 27,028,404.00 LBP )
● Reference: cbip
● Pricing Date: 01/09/2017
● Type: Medicine Non Marketed

● Country: Sweden
● Package Size: 4
● Public Price: 11180.73 SEK ( 94,007,577.84 LBP )
● Pack size unit used: 4
● Cost/Unit: 2795,1825 SEK ( 23,500,360.00 LBP )
● Pharmacy Price: 10916.16 SEK ( 91783073.28 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 4x0,5ml
● Public Price: 9858.9 NOK ( 79,896,525.60 LBP )
● Pack size unit used: 4
● Cost/Unit: 2464,725 NOK ( 19,968,256.00 LBP )
● Pharmacy Price: 7666.47 NOK ( 62129072.88 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 03/06/2019
● Type: Medicine Withdrawn

● Country: Turkey
● Package Size: 4
● Public Price: 4353.45 TRY ( 11,667,246.00 LBP )
● Pack size unit used: 4
● Cost/Unit: 1088,3625 TRY ( 2,915,840.00 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Finland
● Package Size: 4x150µg
● Reference: Kela
● Pricing Date: 13/03/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info